Research Associate (CIRCULIFE Research Group - University of Leicester) • Registered Nurse • Wellcome Trust Doctoral Research Fellow, Loughborough University
Leicester has been recognised as one of the top recruiting sites to a major national study aiming to improve outcomes for people with life‑threatening blocked leg arteries.
The #CLARITYPAD trial, led in Leicester by Mr Badri Vijaynagar, Consultant Vascular and Endovascular Surgeon, is part of a national collaboration with the Centre for Trials Research at Cardiff University and the University of Bristol.
Since recruitment began in January 2025, Leicester rapidly became one of the highest‑recruiting centres in the country. This achievement reflects the dedication of local clinical teams and Leicester’s strong national reputation in cardiovascular and vascular research.
Congratulations to the whole research team, who form part of the #NIHRLeicesterBRC's Cardiovascular theme.
For more information visit https://t.co/6fDE2GRxKB or email [email protected]
🗣️ Great chat w/ @finbo1977 on The Nurse Researcher Podcast: my nursing journey from critical care→ clinical research→ Wellcome Trust-funded PhD @lborouniversity@lhiip_dtp
💡NMAHPs (or supporting managers),if research/academia fits your future, this episode/podcast is for you
Actor and comedian Stephen Fry is encouraging more people to get involved in research to help improve treatments and care for everyone.
This comes after yesterday's launch of the government's Men's Health Strategy, which outlines how we will fund and support research into areas such as mental health and prostate cancer.
Could you take part in research too? Find out more at https://t.co/VRBUhmdoOR
📷 Claudio Raschella
NEWS 📸| Funding from the @NIHRresearch announced today will support the creation of a global vascular research centre to turbocharge research and treatment for patients with artery disease.
CIRCULIFE aims to help patients with Peripheral Artery Disease (#PAD) or Abdominal Aortic Aneurysm (#AAA) live longer, healthier lives and will fund a team of researchers, doctors, and patients working together to design simple checklists, apps, exercise advice, and patient-friendly materials.
Leading the new centre, based at the #NIHRLeicesterBRC, will be @uniofleicester Professor Athanasios Saratzis @a_saratzis
Full story: ➡️ https://t.co/d91eAc7aiM
#research #Researchprofessorship #cardiovascularresearch
A team led by Consultant Vascular and Endovascular Surgeon Dr Badri Vijaynagar, has performed Europe’s first surgery using two dissolving artery scaffolds at the Glenfield Hospital.
Read more on our website: https://t.co/xzaign8uhn
News | New genetic test for deadly disease to be explored in University research programme
👉 https://t.co/gzlpCCljQ7
A new genetic test could target those most at risk of Abdominal Aortic Aneurysms (AAA).
#CitizensOfChange | @Matt_J_Bown | @g_andre_ng
Register below for what should be an interesting webinar discussing PPIE in vascular research in Leicester and the UK.
👇
NIHR Webinar Series - 9 - The Benefits of Public Engagement in Surgical Research: Design, Delivery and Troubleshooting https://t.co/epTMt9Ebi3
The cardiovascular research team has been shortlisted for the Outstanding Contribution award for non-clinical teams, in this year's UHL Recognition Awards. They were nominated for their excellence in building trust in communities, to broaden participation in research.
Feels familiar? Here at Diabetes UK, we understand the extra decisions that go into exercising 🏃
Don't forget, we're here to help with a website full of tips, our online peer support forum and our helpline of people that just get it.
Head to https://t.co/go4sEE1D0G
Our organ donation nurses need you to help them save lives, by confirming your decision to donate on the NHS Organ Donor Register.
To register, or check that you’re registered, visit https://t.co/lpkbGvc5Ka, use the NHS apps in England and Wales, or call 0300 123 23 23.
Why 7,000 steps per day is just as good as 10,000
Dr Mhairi Morris @LboroSSEHS spoke to @theipaper about the benefits of regular exercise 🚶♀️🚶♂️
https://t.co/ECmatEisho
A UHL surgeon has carried out the first operation in the UK using a state-of-the-art implant for the treatment of aortic valve disease. Giovanni Mariscalco led a team at the Glenfield Hospital in using the new pre-assembled @EdwardsEurope KONECT RESILIA aortic valve conduit.
After more than 30 years of research funded by Breakthrough T1D, we have arrived at a historic moment. Today, teplizumab has been licensed for use in the UK by the MHRA.🚨
This breakthrough treatment is the first of its kind to delay the onset of type 1 diabetes (T1D) in people at high risk of developing the condition. It represents a seismic shift in how we think about T1D and approach its treatment.
MHRA approval is a critical milestone, and now teplizumab must go through the NICE (National Institute for Health and Care Excellence) technology appraisal process.
Read the full story here 📖: https://t.co/XbNqRvFmsQ
#Type1Diabetes #T1D #GBDoc
[Image 1: Gradient blue and pink background with text that reads: The MHRA has approved teplizumab for use in the UK.
Image 2: Text on a bright blue background that reads: The Medicines and Healthcare products Regulatory Agency (MHRA) has officially approved teplizumab, the first disease-modifying treatment for type 1 diabetes (T1D).
This is a historic moment.
Image 3: White text on a dark blue background reads: Teplizumab can delay the onset of T1D in people in the early stages of the condition by up to three years.
Thanks to your continued support, Breakthrough T1D helped fund the early research that made this treatment possible.
Image 4: Text on a light pink background reads: Before teplizumab can be made available through the NHS, it must go through a National Institute for Health and Care Excellence (NICE) appraisal. We'll keep advocating until this treatment is accessible to everyone who could benefit from it.]
Develop your leadership and management skills with our 15 free online modules. They share the latest leadership tools to enable you to reflect on and practise new approaches.
Login or register on NIHR Learn to find out more:
https://t.co/jyhnh0CLyd
Please share this survey request as widely as possible and help us to find out how much people really do know about Peripheral Artery Disease
#PADawareness@LeicsVascular
🧠 Tirzepatide doesn’t just reduce appetite—it rewires the brain.
- - -
A new Nature Medicine Phase 1 RCT (n=114) explored how tirzepatide changes eating behavior—and the brain’s response to food—in people with overweight or obesity.
📉 Key Findings at 3–6 Weeks
🔹-524 kcal/day intake vs. placebo by week 3
🔹↓ Brain activation to high-fat, high-sugar foods in the orbitofrontal cortex, cingulate gyrus, hippocampus, and medial frontal gyrus
🔹Fewer cravings for sweets, fast food, carbs, and fats
🔹Reduced impulsivity and tendency to overeat
🔹–7.0 kg weight loss at 6 weeks with tirzepatide vs. –3.7 kg (liraglutide) and –0.6 kg (placebo)
🧪 Clinical translation:
Obesity is not a failure of willpower—it’s a neurobehavioral disease.
Tirzepatide didn’t increase “restraint” or “discipline”—it reduced the drive to eat by dampening brain responses to food cues.
This is mounting evidence that drug therapy doesn’t just affect appetite—it reshapes brain circuits tied to craving, reward, and satiety.
➡️ We need to stop treating obesity like a lifestyle “choice” and start treating it like the chronic, biologically mediated condition it is.
📎https://t.co/uGcOEAsToJ
#Obesity is a common - but often misunderstood and under-treated.
NIHR Leicestershire & Northamptonshire CRDC is supporting new #clinicalresearch into potential new treatments.
Want to take part?
Join our research registry to hear about future studies: https://t.co/GNLhbrf7L4